As for the clinical phase of CML, the chronic phase is the first stage of the disease, and it is well known that about 80–90% of patients Ph+ in this phase, as found in the present study, with 80% of patients testing positive for the presence of a BCR::ABL1 mRNA variant [29]. Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.